CoreCard Corp Files 8-K on Shareholder Votes and Financials

TL;DR

CoreCard filed an 8-K on 10/28/25 covering shareholder votes, other events, and financials.

AI Summary

CoreCard Corporation filed an 8-K on October 28, 2025, reporting on the submission of matters to a vote of security holders, other events, and financial statements and exhibits. The filing details the company's principal executive offices located at One Meca Way, Norcross, Georgia, and its telephone number.

Why It Matters

This filing provides an update on CoreCard Corporation's corporate governance and financial reporting activities, which are important for investors to track company operations and compliance.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (8-K) that typically reports on corporate events and does not inherently signal significant new risks.

Key Players & Entities

• CoreCard Corporation (company) — Registrant
• October 28, 2025 (date) — Date of earliest event reported
• One Meca Way, Norcross, Georgia 30093 (location) — Address of principal executive offices
• 770-381-2900 (phone_number) — Registrant's telephone number
• Georgia (location) — State of incorporation
• 58-1964787 (tax_id) — I.R.S. Employer Identification No.

FAQ

Key Financial Figures

• $0.01 — nge on which registered Common Stock , $0.01 par value per share CCRD New York St

Filing Documents

• ins20251028_8k.htm (8-K) — 39KB
• 0001437749-25-031974.txt ( ) — 169KB
• ccrd-20251028.xsd (EX-101.SCH) — 3KB
• ccrd-20251028_def.xml (EX-101.DEF) — 11KB
• ccrd-20251028_lab.xml (EX-101.LAB) — 15KB
• ccrd-20251028_pre.xml (EX-101.PRE) — 11KB
• ins20251028_8k_htm.xml (XML) — 3KB

07. Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders. On October 28, 2025, CoreCard Corporation (the " Company ") held a special meeting of stockholders (the " Special Meeting ") to consider certain proposals related to the Agreement and Plan of Merger, dated as of July 30, 2025 (the " Merger Agreement "), by and among the Company, Euronet Worldwide, Inc., a Delaware corporation (" Euronet "), and Genesis Merger Sub Inc., a Georgia corporation and wholly owned subsidiary of Euronet (" Merger Sub "). The Merger Agreement provides that, among other things, upon the terms and subject to the conditions set forth therein, Merger Sub will be merged with and into the Company (the " Merger "), with the Company surviving as a wholly owned subsidiary of Euronet. At the close of business on September 18, 2025, the record date of the Special Meeting, there were 7,792,382 shares of common stock of the Company, par value $0.01 per share (" Common Stock "), outstanding, each of which was entitled to one vote with respect to each proposal voted on at the Special Meeting. A total of 5,694,934 shares of Common Stock, representing approximately 73.08% of the outstanding shares of Common Stock entitled to vote at the Special Meeting, were present in person or by proxy, constituting a quorum for the transaction of business at the Special Meeting pursuant to the Company's amended and restated bylaws. The following is a summary of the proposals voted on by Company stockholders at the Special Meeting based on the final, certified report of the voting result by the independent inspector of election. The definitive proxy statement on Schedule 14A related to the Special Meeting that was filed by the Company with the Securities and Exchange Commission (the " SEC ") on September 26, 2025 contains a description of the following proposals considered at the Special Meeting. There were no recorded broker non-votes. Proposal 1: The Merger Agreement Proposal The proposal to adopt and

01. Other Events

Item 8.01. Other Events. Following receipt of approval by the Company's stockholders of the Merger Proposal, the parties intend to close the Merger on October 30, 2025. Completion of the Merger remains subject to the satisfaction or waiver of customary closing conditions set forth in the Merger Agreement. Following the Merger, the Common Stock will be delisted from the New York Stock Exchange and shares of the Common Stock will cease to be publicly traded.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description of Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) Cautionary Statement Regarding Forward-Looking Statements This Current Report on Form 8-K (this " Report ") contains statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 (the " Securities Act ") and Section 21E of the Securities Exchange Act of 1934, each as amended, including statements regarding the Merger, the expected timetable for completing the Merger, and any other statements regarding the Company's future expectations, beliefs, assumptions or future events or performance that are not historical facts. This information may involve risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. These risks and uncertainties include, but are not limited to: the timing to consummate the Merger and the risk that the Merger may not be completed at all or the occurrence of any event, change, or other circumstances that could give rise to the termination of the Merger Agreement, including circumstances requiring the Company to pay Euronet a termination fee pursuant to the Merger Agreement the risk that the conditions to closing of the Merger may not be satisfied or waived potential litigation relating to, or other unexpected costs resulting from, the Merger risks that the Merger disrupts the Company's current plans and operations the risk that certain restrictions during the pendency of the Merger may impact the Company's ability to pursue certain business opportunities or strategic transactions the diversion of management's time on transaction-related issues the risk that any announcements relating to the Merger could have adverse effects on the market price of the Common Stock or operating results and the risk

View Full Filing

View this 8-K filing on SEC EDGAR